ECP 2023 Final Programme

Poster Sessions a Monday 92 Monday, 11 Sept PS-10 019 Tumour-infiltrating lymphocytes (TILs) digital quantification as a relevant prognostic biomarker in high-grade serous ovarian cancer Jesus Machuca-Aguado, Spain A. Conde-Martín, A. Álvarez Muñoz, E. Rodríguez-Zarco, J. Rios Martin, M. Idoate Gastearena 020 Molecular classification of endometrial carcinoma (EC): a single institution experience with 144 ECs exclusively tested by NGS Kvetoslava Michalova, Czech Republic O. Ondic, J. Presl, P. Martinek, N. Hejhalova, A. Hluchy, A. Strakova-Peterikova, M. Michal, M. Michal 021 Tumour infiltrating lymphocytes in early stage high grade serous ovarian cancer: prognosis significance of visual and digital analysis Silvia Molés Caparrós, Spain A. Veliz Dominguez, J. Corredor-García, A. Tenelanda-Santillán, N. Cadavid Fernández, I. Romero, J. López-Guerrero, A. Poveda, I. Carretero-Barrio, B. Pérez-Mies, J. Palacios Calvo 022 Clinicopathological and molecular features of mesonephric-like adenocarcinoma of uterine corpus Carlota Mora, Portugal J. Ferreira, F. Cunha, F. Silva, P. Silva, C. Albuquerque, A. Félix 023 Endocervical adenocarcinoma(ECA): Reclassification as per IECC into HPV associated(HPVA) and HPV independent(H- PVI) using morphology, P16INK4a immunohistochemistry and HR-HPV RNA in situ hybridization(ISH) Kedar Deodhar, India A. Mundada, K. Deodhar, B. Rekhi, S. Menon, N. Mittal, O. Shetty, O. Salvi 024 Characterisation of uterine leiomyosarco- mas: a single-center retrospective study of 19 tumours David Piñol Ballús, Spain A. Prat, S. Acosta, M. Miralles, M. Campos, E. Lerma, A. Gallardo 025 HER2 testing in endometrial carcinoma, a summary of real world initial experience in a large tertiary cancer center Anna Plotkin, Canada E. Olkhov-Mitsel, S. Nofech-Mozes 026 Clinicopathological features of 231 endocer- vical adenocarcinomas, including p16INK4a immunostaining results: a study at a tertiary cancer referral centre, India Bharat Rekhi, India A. Duggad, K. Deodhar, S. Menon, J. Ghosh, S. Gulia, T. Shylasree, A. Maheshwari 027 DNA NGS and immunohistochemical analysis of a large cohort of adult granulosa cell tumors focusing on predictive aberrations Adam Safanda, Czech Republic P. Dundr, N. Hájková, J. Hojný, E. Krkavcová, R. Michálková, J. Laco, J. Škarda, J. Drozenová, R. Matěj, M. Hácová, K. Němejcová 028 Association of PD-L1 expression with clinicopathological and prognostic characteristics in cervical cancer: a single-institution study Ghada Sahraoui, Tunisia F. Sassi, M. Manai, R. Mchiri, R. Doghri, L. Charfi, K. Mrad 029 TLR4 down-regulation identifies high risk HPV infection and integration in cervical squamous cell carcinomas Angela Santoro, Italy M. Pedicillo, I. De Stefano, G. Aquino, M. Tornesello, F. Miele, N. D’Alessandris, G. Scaglione, F. Addante, G. Zannoni, G. Pannone